Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001181431-12-046074
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-16 16:42:42
Reporting Period:
2012-08-14
Filing Date:
2012-08-16
Accepted Time:
2012-08-16 16:42:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1484478 Furiex Pharmaceuticals Inc. FURX Pharmaceutical Preparations (2834) 271197863
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492647 Sherie June Almenoff C/o Furiex Pharmaceuticals, Inc.
3900 Paramount Parkway, Suite 150
Morrisville NC 27560
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-14 50 $18.55 6,050 No 4 P Direct
Common Stock Acquisiton 2012-08-15 950 $18.68 7,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (to buy) $17.80 2022-02-24 10,368 10,368 Direct
Common Stock Stock Options (to buy) $13.16 2021-10-03 65,909 65,909 Direct
Common Stock Stock Options (to buy) $15.00 2021-05-09 46,000 46,000 Direct
Common Stock Stock Options (to buy) $9.11 2020-06-17 131,718 131,718 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-02-24 10,368 10,368 Direct
2021-10-03 65,909 65,909 Direct
2021-05-09 46,000 46,000 Direct
2020-06-17 131,718 131,718 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $18.55 to $18.75. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  2. The options were awarded on 2/24/2012 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
  3. The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
  4. The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
  5. The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.